Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oneness Biotech (4743 TT)
Watchlist
19
Analysis
Health Care
•
Taiwan
Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
03 May 2024 17:15
Announcement The Company'S Board Of Directors Meeting Date Of The First Quarter Of 2024 Consolidated Financial Reports
Attachment
Exchange Announcement •
02 May 2024 17:53
Oneness Biotech Co., Ltd. Receives A Japanese Patent Titled "Topical Formulation For Promoting Wound Healing" On Fespixon Cream (Research Code: On101) .
Attachment
Exchange Announcement •
22 Apr 2024 18:16
Subcutaneous Injection Formulation Of Fb825 To Treat Moderate-To-Severe Atopic Dermatitis Was Greenlighted By Tfda To Proceed With A Ph2 Study
Attachment
Exchange Announcement •
29 Mar 2024 18:08
Submission Of A Phase Ii Clinical Trial Protocol To Taiwan Fda For Subcutaneous Injection Formulation Of Fb825 In Patients With Moderate-To-Severe Atopic Dermatitis
Attachment
Exchange Announcement •
22 Mar 2024 17:16
Oneness Announces The Information About The Investor'S Conference Of 2024 Q1.
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.1
x